Items where Author is "Ihorst, G."
 | Up a level |
Article
Fritsch, K. and Kasenda, B. and Schorb, E. and Hau, P. and Bloehdorn, J. and Moehle, R. and Loew, S. and Binder, M. and Atta, J. and Keller, U. and Wolf, H-H and Krause, S. W. and Hess, G. and Naumann, R. and Sasse, S. and Hirt, C. and Lamprecht, M. and Martens, U. and Morgner, A. and Panse, J. and Frickhofen, N. and Roeth, A. and Hader, C. and Deckert, M. and Fricker, H. and Ihorst, G. and Finke, J. and Illerhaus, G. (2017) High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study). LEUKEMIA, 31 (4). pp. 846-852. ISSN 0887-6924, 1476-5551
Harder, J. and Ihorst, G. and Heinemann, V. and Hofheinz, R. and Moehler, M. and Buechler, P. and Kloeppel, G. and Roecken, C. and Bitzer, M. and Boeck, S. and Endlicher, E. and Reinacher-Schick, A. and Schmoor, C. and Geissler, M. (2012) Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer. BRITISH JOURNAL OF CANCER, 106 (6). pp. 1033-1038. ISSN 0007-0920
Marks, R. and Potthoff, K. and Hahn, J. and Ihorst, G. and Schulte-Moenting, J. and Bertz, H. and Holler, E. and Finke, J. (2007) Reduced-toxicity conditioning with fludarabine, BCNU and melphalan: particular activity against advanced haematological malignancies. BONE MARROW TRANSPLANTATION, 39 (Suppl1). S14. ISSN 0268-3369
